We have previously shown that low levels of RECQL protein is associated with aggressive IBC including larger tumor size, lymph node positivity, high tumor grade, high mitotic index, pleomorphism, dedifferentiation, ER negativity and poor survival [6,7]. This evidence concerns the gene ESR1 and inflammatory breast carcinoma.